# COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits

> **NCT04412473** · — · UNKNOWN · sponsor: **University Hospital, Strasbourg, France** · enrollment: 1000 (estimated)

## Conditions studied

- Sars-CoV2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04412473
- **Lead sponsor:** University Hospital, Strasbourg, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-30
- **Primary completion:** 2021-06
- **Final completion:** 2021-06
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2021-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04412473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04412473, "COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject's Habits". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04412473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*